Prevalence of alpha actinin-3 gene (ACTN3) R577X and angiotensin converting enzyme (ACE) insertion/deletion gene polymorphisms in national and amateur Turkish athletes O Eroğlu, R Zileli, M Ali Nalbant, K Ulucan Cellular and Molecular Biology 64 (5), 2018 | 25 | 2018 |
The Relationship among the performance and the ACE I/D and ACTN3 R577X polymorphisms and some anthropometric factors in arm wrestlers R Zileli, O Eroğlu, MA Nalbant, K Ulucan Cellular and Molecular Biology 69 (5), 1-5, 2023 | | 2023 |
Effects of Pyrroloquinoline Quinone (PQQ) and Coenzyme Q10 on mitochondrial genes, mitomiRs and cellular properties in HepG2 cell line M Nalbant, O Eroğlu Cellular and Molecular Biology 69 (4), 2023 | | 2023 |
HEPG2 hücre hattında Pirolokinolin Kinon (PQQ) ve Koenzim Q10’in mitokondriyal genler, MitomiR’ler ve hücresel özellikler üzerine etkilerinin incelenmesi MA Nalbant Bilecik Şeyh Edebali Üniversitesi, Fen Bilimleri Enstitüsü, 2023 | | 2023 |
Which Polymorphism Is The Distinguishing Factor For Fitness Athletes: The Ace Indel or Actn3 rs1815739? O Eroğlu, R Zileli, MA Nalbant, T Polat, ÖÖ Yılmaz, BT Aslan, K Ulucan Journal of Basic and Clinical Health Sciences 8 (2), 319-326, 2021 | | 2021 |
Profesyonel, amatör Türk atletlerde ve sedanterlerde A-aktinin-3 kodon 577 ve anjiyotensin-1 dönüştürücü enzim insersiyon/delesyon polimorfizminin dağılımı ve performansla ilişkisi MA Nalbant Bilecik Şeyh Edebali Üniversitesi, Fen Bilimleri Enstitüsü, 2017 | | 2017 |
Investigation of Cytotoxic and Anti proliferative effects of Doxorubucin DOX and Caffeic Acid Phenetyl Ester CAPE on MDA MB 231 breast cancer cell line O Eroğlu, E Güvenir Çelik, M Çelen, MA Nalbant, D Sağraç, K Erdoğan, ... 4th International Bau Drug Design Congress, 2016 | | 2016 |
Investigation of Cytotoxic and anti-proliferative effects of Doxorubicin (DOX) and Caffeic Acid Phenethyl Ester (CAPE) on MDA-MB 231 breast cancer cell line O EROGLU, EG CELIK, H KAYA, M CELEN, MA NALBANT, D SAGRAC, ... | | |
Investigation of Cytotoxic Effect of Doxorubicin, 5-Fluorouracil, Propranolol and Triple Combined Treatment in MCF-7 Breast Cancer Cell Line. O EROGLU, EG CELİK, M CELEN, H KAYA, MA NALBANT, E KORKUT, ... | | |